New Oral Anticoagulants in Prophylaxis of Venous Thromboembolic Disease in Major Orthopedic Surgery

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 3, 2015-12 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite

Rationale for Development of New Oral Anticoagulants

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 89-91

Bentham Science Publishers

Access to resources Recommend Favorite

New insights and therapeutic strategies for postcardiac transplantation coronary artery disease

By Rabinovitch M.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2585-2586

Elsevier

Access to resources Recommend Favorite

Apixaban in Venous Thromboembolism in an Era of New Oral Anticoagulants

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 139-147

Bentham Science Publishers

Access to resources Recommend Favorite

Gender, Hyperlipidemia, and Coronary Artery Disease

By Shepard Dale R.   Jneid Hani   Thacke Holly L.  

Comprehensive Therapy, Vol. 29, Iss. 1, 2003-03 ,pp. : 7-17

Humana Press, Inc

Access to resources Recommend Favorite